Catalyst Wire Dossier Catalyst Wire Dossier

RYANODEX DANTROLENE SODIUM

DANTROLENE SODIUM · Eagle Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for RYANODEX DANTROLENE SODIUM, covering 2014-07-22 to 2024-04-02. Get the full timeline:

Most recent: FDA Approved: RYANODEX DANTROLENE SODIUM — Supplemental Application (Eagle Pharmaceuticals, Inc.)

See pricing